Ocular Therapeutix Inc. (OCUL)

8.16

0.45 (5.84%)

At close: Apr 28, 2025, 3:59 PM

8.10

-0.74%

After-hours: Apr 28, 2025, 06:53 PM EDT

Ocular Therapeutix Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-193.51M	-80.74M	-71.04M	-6.55M	-155.64M	-86.37M	-59.98M	-63.39M	-44.7M
Depreciation & Amortization	3.79M	2.98M	2.11M	2.42M	2.77M	2.53M	2.29M	1.63M	881K
Stock-Based Compensation	33.11M	17.82M	16.96M	14.98M	7.53M	8.76M	7.48M	7.32M	5.96M
Other Working Capital	n/a	-2.81M	2.88M	4.24M	11.58M	1.08M	1.45M	2.6M	2.27M
Other Non-Cash Items	21.93M	-2.9M	-8.99M	4.63M	4.41M	3.68M	397K	408K	371K
Deferred Income Tax	n/a	n/a	n/a	-78.12M	86.19M	-4.3M	n/a	9K	1.42M
Change in Working Capital	n/a	-7.41M	1.35M	-2.9M	1.18M	-1.88M	585K	3.55M	2.08M
Operating Cash Flow	-134.68M	-70.23M	-59.6M	-65.55M	-53.55M	-77.58M	-49.23M	-50.47M	-34M
Capital Expenditures	-1.29M	-6.09M	-3.71M	-1.19M	-841K	-2.24M	-1.89M	-8.25M	-1.92M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5K	2K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3M	-41.7M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	38.2M	80.68M
Other Investing Acitivies	n/a	n/a	-3.71M	n/a	n/a	n/a	n/a	114K	-1.5M
Investing Cash Flow	-1.29M	-6.09M	-3.71M	-1.19M	-841K	-2.24M	-1.89M	27.07M	35.57M
Debt Repayment	n/a	56.35M	n/a	-445K	n/a	37.27M	6.38M	2.4M	n/a
Common Stock Repurchased	n/a	n/a	n/a	985K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	15.76M	-3.78M	1.45M	3.3M	3.33M	529K	694K	370K	-42K
Financial Cash Flow	332.11M	169.83M	1.45M	2.85M	228.01M	75.34M	68.64M	32.01M	585K
Net Cash Flow	196.15M	93.51M	-61.86M	-63.89M	173.62M	-4.47M	17.52M	8.6M	2.15M
Free Cash Flow	-135.97M	-76.32M	-63.32M	-66.74M	-54.4M	-79.82M	-51.12M	-58.73M	-35.92M